Maureen Goodenow
#97,734
Most Influential Person Now
American scientist and professor
Maureen Goodenow's AcademicInfluence.com Rankings
Maureen Goodenowbiology Degrees
Biology
#7532
World Rank
#10469
Historical Rank
Virology
#406
World Rank
#415
Historical Rank
Immunology
#953
World Rank
#977
Historical Rank
Microbiology
#1045
World Rank
#1166
Historical Rank
Download Badge
Biology
Maureen Goodenow's Degrees
- PhD Microbiology University of California, San Francisco
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Maureen Goodenow Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maureen Goodenow is an American scientist and Professor of Pathology, Immunology, and Laboratory Medicine. She is best known for her work on HIV/AIDS research and advocacy. Biography Goodenow received her B.A. in biology from Fordham University, and her Ph.D. in 1983 from the Albert Einstein College of Medicine. From 1983 to 1987, she completed postdoctoral training at Memorial Sloan-Kettering Cancer Center. From 1998 to 2016, she was a member of the faculty of the University of Florida where she held the Stephany W. Holloway University Chair in AIDS Research. In 2016, Goodenow was appointed as the Associate Director for AIDS Research and Director of the NIH Office of AIDS Research at the National Institutes of Health.
Maureen Goodenow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. (1989) (363)
- Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1 (1998) (226)
- Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants (1999) (223)
- HIV-1 infection (2003) (206)
- Rapid telomere shortening in children. (1999) (180)
- Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy (2010) (161)
- Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). (2000) (144)
- Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update (2015) (106)
- Spatial phylodynamics of HIV-1 epidemic emergence in east Africa (2009) (102)
- HIV‐1 coreceptor preference is distinct from target cell tropism: a dual‐parameter nomenclature to define viral phenotypes (2006) (100)
- HIV-1 Activates Macrophages Independent of Toll-Like Receptors (2008) (95)
- Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease. (2004) (84)
- Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. (1996) (84)
- Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages. (1999) (81)
- Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. (1994) (80)
- Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir. (2006) (79)
- Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. (2002) (78)
- Retroviral proteases (2002) (76)
- High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania (2008) (72)
- Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. (1978) (71)
- Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo (1993) (69)
- Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus (1995) (69)
- Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N. (2003) (68)
- Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas. (1984) (66)
- Human immunodeficiency virus type 1 (HIV‐1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages (2003) (64)
- Phylodynamics of HIV-1 in Lymphoid and Non-Lymphoid Tissues Reveals a Central Role for the Thymus in Emergence of CXCR4-Using Quasispecies (2007) (62)
- HIV-1 infection of lung alveolar fibroblasts and macrophages in humans. (1990) (57)
- The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. (2001) (47)
- Two-Year Clinical and Immune Outcomes in Human Immunodeficiency Virus–Infected Children Who Reconstitute CD4 T Cells Without Control of Viral Replication After Combination Antiretroviral Therapy (2004) (45)
- Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges (2013) (44)
- Complex Determinants in Human Immunodeficiency Virus Type 1 Envelope gp120 Mediate CXCR4-Dependent Infection of Macrophages (2005) (44)
- Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation (1997) (42)
- Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. (2008) (41)
- The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease. (2008) (40)
- SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. (1998) (39)
- 5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses (1987) (39)
- The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. (2008) (39)
- Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth. (2014) (37)
- Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects (2015) (37)
- An exploratory algorithm to identify intra-host recombinant viral sequences. (2008) (36)
- Impact on Genetic Networks in Human Macrophages by a CCR5 Strain of Human Immunodeficiency Virus Type 1 (2004) (36)
- T-Cell Receptor Vβ Repertoire CDR3 Length Diversity Differs within CD45RA and CD45RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children (2000) (34)
- Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. (1997) (33)
- High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems (2012) (33)
- Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. (2003) (33)
- Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. (1998) (32)
- Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease. (1994) (31)
- 13. HIV-1 infection. (2003) (30)
- Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. (2001) (30)
- Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources. (2011) (29)
- Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease. (2002) (29)
- Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. (1997) (28)
- Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection (2014) (28)
- Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells. (2001) (27)
- IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. (2010) (27)
- Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. (2005) (27)
- C-ski transcripts with and without exon 2 are expressed in skeletal muscle and throughout chick embryogenesis. (1993) (26)
- Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology. (2012) (24)
- HIV‐1 fitness and macrophages (2003) (23)
- Multiple independent lineages of HIV-1 persist in breast milk and plasma (2011) (23)
- Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents. (2004) (23)
- A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses. (1996) (23)
- Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro (1980) (22)
- Antiretroviral Therapy Restores Diversity in the T-Cell Receptor Vβ Repertoire of CD4 T-Cell Subpopulations among Human Immunodeficiency Virus Type 1-Infected Children and Adolescents (2009) (22)
- Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061 (2015) (22)
- Molecular epidemiology of HIV type 1 CRF02_AG in Cameroon and African patients living in Italy. (2011) (22)
- IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus (2013) (21)
- Unexpected Maintenance of Hepatitis C Viral Diversity following Liver Transplantation (2012) (21)
- High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch. (2013) (21)
- High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance. (2008) (21)
- C-ski cDNAs are encoded by eight exons, six of which are closely linked within the chicken genome. (1992) (20)
- Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS. (2014) (19)
- Molecular analysis of highly enriched populations of T-cell-depleted monocytes (1995) (19)
- Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles (2015) (18)
- Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors. (1998) (17)
- Co‐receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient? (2000) (17)
- Human Lymphocyte Proliferation Responses following Primary Immunization with Rabies Vaccine as Neoantigen (2001) (17)
- Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques (2015) (17)
- Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells. (2008) (17)
- Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice (1985) (14)
- Editorial: Passive aggressive avoidance of SAMHD1 restriction by HIV‐1 (2015) (13)
- Effects of PRE and POST therapy drug‐pressure selected mutations on HIV‐1 protease conformational sampling (2014) (11)
- Expression of the c-ski proto-oncogene during cell cycle arrest and myogenic differentiation. (1995) (11)
- Neuroglial-specific factors and the regulation of retrovirus transcription. (1994) (10)
- HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication. (2017) (10)
- Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease. (2007) (10)
- Genetically and epidemiologically related “non‐syncytium‐inducing” isolates of HIV‐1 display heterogeneous growth patterns in macrophages (2000) (10)
- Absence of trisomy 15 in chemically induced murine T-cell lymphomas. (1986) (9)
- Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice. (1984) (9)
- Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children (2008) (8)
- A comparison of gag-pol precursor cleavage in naturally arising HIV variants. (1998) (8)
- Pathogenesis and natural history of HIV infection. (1991) (7)
- Cloning, expression and kinetic characterization of the feline immunodeficiency virus proteinase. (1991) (7)
- Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor (2009) (7)
- Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV. (2019) (6)
- Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy. (2018) (5)
- HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST (2016) (5)
- HPV-QUEST: A highly customized system for automated HPV sequence analysis capable of processing Next Generation sequencing data set (2012) (4)
- Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana (2022) (3)
- Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH). (2019) (3)
- Longitudinal analysis of intra-host simian immunodeficiency virus recombination in varied tissues of the rhesus macaque model for neuroAIDS. (2013) (3)
- Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS) (1998) (2)
- T-Cell Receptor Vb Repertoire CDR3 Length Diversity Differs within CD45RA and CD45RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children (2000) (2)
- Tenofovir has minimal effect on biomarkers of bone health in Youth with HIV receiving initial antiretroviral therapy. (2019) (2)
- Persistent viruria due to reovirus in a patient treated for Hodgkin's disease in a protected environment. (1970) (2)
- Systems mapping of HIV-1 infection (2012) (1)
- Normal T Cell Response Following Tetanus Immunization in X-Linked Agammaglobulinemia (XLA) (1999) (1)
- T-Cell Receptor V b Repertoire CDR 3 Length Diversity Differs within CD 45 RA and CD 45 RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children (2000) (1)
- Unique genotypic features of HIV-1 C gp41 membrane proximal external region variants during pregnancy relate to mother-to-child transmission via breastfeeding (2020) (1)
- Molecular Docking-Based Screening for Novel Inhibitors of the Human Immunodeficiency Virus Type 1 Protease that Effectively Reduce the Viral Replication in Human Cells (2020) (1)
- High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems (2012) (1)
- Structure of HIV-1 protease mutant bound to indinavir (2006) (1)
- Lymphocyte Activation and Bone Turnover in HIV-Infected Young Adults; A Sub-Study of Adolescent Medicine Trials Network Protocol 061 (2016) (1)
- Systems mapping of HIV-1 infection (2012) (1)
- Multiple Lymphocyte Lineages are Involved in Immunoreconstitution following Ritonavir Therapy in HIV-infected Children ♦ 42 (1998) (0)
- Structure of HIV-1 protease bound to atazanavir (2006) (0)
- Role of the Matrix-Capsid Cleavage Site Polymorphism S124V of HIV-1 Sub-subtype A2 in Gag Polyprotein Processing (2020) (0)
- HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication (2017) (0)
- BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line. (1993) (0)
- CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Rapid Telomere Shortening in Children (2016) (0)
- Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects (2015) (0)
- Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana (2022) (0)
- Activation of human macrophages by the endogenous toll-like receptor 4 ligand high molecular weight hyaluronan (101.20) (2011) (0)
- Human Immunodeficiency Virus Type 1 Long Terminal Repeat Quasispecies Differ in Basal Transcription and Nuclear Factor Recruitment in Human Glial Cells and Lymphocytes (1998) (0)
- Protease Inhibitors and HIV-1 Genetic Variability in Infected Children (2002) (0)
- Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection (2014) (0)
- Role of NIH in the Ending the HIV Epidemic in the US Initiative: Research Improving Practice. (2022) (0)
- HIV-1, AIDS, and Related Malignancies (2006) (0)
- MATERNAL HIV-1 TRANSMISSION IS ASSOCIATED WITH HIGH LEVELS OF PROVIRUS IN BLOOD CD4+ T CELLS † 1096 (1996) (0)
- Growth in Primary Macrophage Cultures, Not Syncytium Induction, Distinguishes Viral Isolates from Children with Rapidly Progressive HIV Disease from those with Long Term Survival (1999) (0)
- Memory CD27+ B220− B Cell Subpopulation is Decreased in Both Systemic Lupus Erythematosus (SLE) and Common Variable Immune Deficiency (CVID) (2009) (0)
- Methionine requirement, substitution and depletion in cell cultures of experimental and human neoplasms and normal cells. Abstr. (1978) (0)
- SELECTIVE EXPANSION OF T CELL RECEPTOR (Vβ) GENE FAMILIES IN SLE NEPHRITIS. • 2346 (1996) (0)
- Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles (2015) (0)
- HIV-1 primes macrophages while evading Toll-Like Receptor (TLR) signaling: A systems biology approach (2009) (0)
- Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy (2021) (0)
- Reduction of HIV-1 innate immune activation by protease inhibitors (154.15) (2011) (0)
- Measurements of Plasma Lipopolysacharide (LPS), Endotoxin Core IgM Antibody (EndoCAb), Soluble CD14 (sCD14), TNFα, and Soluble CD62L (sCD62L) Levels to Assess Microbial Translocation and Immune Activation in HIV-Infected Children and Adolescents (2009) (0)
This paper list is powered by the following services:
Other Resources About Maureen Goodenow
What Schools Are Affiliated With Maureen Goodenow?
Maureen Goodenow is affiliated with the following schools:
